 |
|
|
| |
Injection Site Reactions with Subcutaneous Lenacapavir
Administration at Alternate Injection Sites
|
| |
| |
25th International AIDS Conference (AIDS 2024); July 22–26, 2024; Munich, Germany
Gary Saunders1*, Eva Mortensen2, Gong Shen2, Aryun Kim2
1Gilead Sciences, Inc., Cambridge, United Kingdom; 2Gilead Sciences, Inc., Foster City, California, United States
*Presenting author
|
| |
|
|
|
|
|
